View our comprehensive portfolio of products for drug development and patient diagnosis and monitoring
Our products are trusted worldwide in research, clinical, and commercial laboratory settings.
Functional and biomarker assays for the exploration of every angle of the complement system
Our cell-based bioassays are based on iLite® technology – a cleverly designed cell-based assay system with reporter gene readouts
AAV Neutralizing Antibody (NAb), Total Antibody (TAb), and Complement Activation assays designed to provide a comprehensive view of vector immunogenicity
Solutions for detecting and semi-quantitating IgG antibodies against CCP
Our extensive CRO Services offer bioanalysis, biomarker discovery, and GMP QC testing.
With over 30 years of experience in autoimmune diagnostics, our ISO15189-certified specialist laboratory can help you reach the correct diagnosis. We also provide testing services and support for therapeutic drug monitoring.
Let us develop a custom iLite® cell line tailored to your needs.
Our cell services are highly reliable and innovative, tailored to your manufacturing needs
We are pleased to introduce a new edition of Svar’s Complement System Specialist Review, an invaluable resource designed to enhance the understanding of the complement system’s role in health and disease, and its potential use in diagnostics and treatment development.
Building upon and expanding previous editions, the authors — Prof. Tom Eirik Mollnes, Prof. Peter Garred, and Prof. Reinhard Würzner — offer a comprehensive overview of the complement system’s physiological functions and its numerous pathological implications, while also examining current research trends, the complement therapeutics landscape, and best practices in complement testing.
Growing evidence demonstrates the involvement of the complement system in a wide range of diseases and pathological processes, driving a mounting interest in the development of complement‑targeted therapeutics. This Specialist Review provides an up-to-date review of some conditions in which complement dysregulation is most clearly defined, and also highlights the expanding therapeutic potential of complement modulation across multiple disease areas, including the proposed role of complement modulation in cancer therapy.
Get your copy of the new edition of Svar’s Complement System Specialist Review to access essential, expert‑driven insights that deepen your understanding of the complement system and provide a solid foundation for advancing your complement research.